Keyword: Illumina

News

Merck Serono and Illumina in Oncology Diagnostics Pact

11.03.2015 - Merck Serono, the biopharmaceutical business of Germany's Merck KGaA, and US biotechnology company Illumina, based at San Diego, California, plan to collaborate on expanding the...

News

Roche Acquires DNA Sequencing Firm

03.06.2014 - Swiss pharmaceutical producer Roche has announced plans to buy privately held US gene-sequencing firm Genia Technologies for up to $350 million, securing access to a technology...

News

Alexion Valuation Could Choke Any Roche Bid

15.07.2013 - Buying Alexion Pharmaceuticals would help Roche make a splash in the newly lucrative area of rare or so-called orphan diseases, but it could command a price that the Swiss...

News

Roche Open to Gene-Sequencing Acquisition

19.12.2012 - Swiss drugmaker Roche would still consider buying a gene-sequencing company to fit its strategy of tailoring treatments to specific patients, after dropping a $6.8 billion bid for...

News

Surge in Biotech Deals to Unlock Big Investor Profits

18.07.2012 - Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost...

News

Astra Fuels Biotech M&A with $1.3 bln Ardea Buy

23.04.2012 - AstraZeneca has agreed to buy U.S. company Ardea Biosciences for $1.26 billion, giving it a new gout drug to bolster its weak pipeline in a deal that feeds a wave of M&A in the...

News

Roche Steps Back from Illumina Acquisition

20.04.2012 - Roche dropped its bid to buy the gene-sequencing leader Illumina this week after Illumina's shareholders made it clear at the company's annual meeting that the terms were...

News

Roche Q1 Sales Flat as Illumina Bid Battle Rages

12.04.2012 - Swiss drugmaker Roche dangled the prospect of a higher offer before reluctant U.S. bid target Illumina on Thursday along with broadly flat first-quarter sales supported by its top...